StockNews.com Initiates Coverage on Genocea Biosciences (NASDAQ:GNCA)
Equities research analysts at StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research note issued on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Price Performance Genocea Biosciences has a 1-year low of $0.00 and a 1-year high of $0.00. The company […]
Equities research analysts at StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research note issued on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Price Performance Genocea Biosciences has a 1-year low of $0.00 and a 1-year high of $0.00. The company […]
